EP2651978

LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP11811089A
Filing Date
Dec 12, 2011
Status
Patent Maintained As Amended
Dec 10, 2021
Grant Date
Jan 12, 2022
External Links
Slate, Register

Biblio Summary

The patent EP2651978B2 was granted on Jan 12, 2022 by Laboratoire Français Du Fractionnement Et Des Biotechnologies The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MILTENYI BIOTEC B.V. & CO. KGFeb 9, 2018ADMISSIBLE

The table below shows the patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3481415Stable Liquid FibrinogenSep 6, 20233
EP3806891Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific AntibodyAug 2, 20231
EP3390452New Use Of An Anti-Cd303 Transmembrane Protein AntibodyMay 26, 20211

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.